BATON-CRC: a phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer
Authors | |
---|---|
Year of publication | 2016 |
Type | Article in Periodical |
Magazine / Source | Journal of Experimental and Clinical Cancer Research |
Citation | |
Web | http://dx.doi.org/10.1158/1078-0432.CCR-15-3117 |
Doi | http://dx.doi.org/10.1158/1078-0432.CCR-15-3117 |
Keywords | Phase I-III trials; gastrointestinal cancers: colorectal; growth factor receptors and other surface molecules as targets for therapy |